Novel diphenyl ethers: Design, docking studies, synthesis and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli
Novel diphenyl ether compounds inhibit the enoyl-acyl carrier protein reductase of Plasmodium falciparum and Escherichia coli. Some of these compounds also show potency against in vitro cultures of the two pathogens. We designed some novel diphenyl ethers and determined their binding energies for En...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 14; no. 23; pp. 8086 - 8098 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Elsevier Ltd
01.12.2006
Elsevier Science |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Novel diphenyl ether compounds inhibit the enoyl-acyl carrier protein reductase of Plasmodium falciparum and Escherichia coli. Some of these compounds also show potency against in vitro cultures of the two pathogens.
We designed some novel diphenyl ethers and determined their binding energies for Enoyl-Acyl Carrier Protein Reductase (ENR) of Plasmodium falciparum using Autodock. Out of these, we synthesized the promising compounds and tested them for their inhibitory activity against ENRs of P. falciparum as well as Escherichia coli. Some of these compounds show nanomolar inhibition of PfENR and low micromolar inhibition of EcENR. They also exhibit low micromolar potency against in vitro cultures of P. falciparum and E. coli. The study of structure–activity relationship of these compounds paves the way for further improvements in the design of novel diphenyl ethers with improved activity against purified enzyme and the pathogens. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/j.bmc.2006.07.034 |